TRNS insider filing: Rudow sells shares, granted RSUs and exercisable option
Rhea-AI Filing Summary
Lee D. Rudow, President, CEO and Director of Transcat, Inc. (TRNS), reported multiple equity transactions dated 08/21/2025. The filing shows a disposition of 93,864 shares of Transcat common stock and the grant of several restricted stock unit (RSU) awards that convert one-for-one into common shares: 14,782, 12,500, 3,925, and 8,785 RSUs. Specific vesting schedules are provided for each award, with portions vesting on March 28, 2026, March 27, 2027, and March 25, 2028 as noted.
In addition, a stock option covering 10,000 shares with an exercise price of $63.17 is reported as fully exercisable as of the report date. The report was signed by an attorney-in-fact on behalf of Mr. Rudow on 08/25/2025. The RSU grants are identified as issued under the Transcat, Inc. 2021 Stock Incentive Plan and are described as transactions exempt under Rule 16b-3.
Positive
- None.
Negative
- None.
Insights
TL;DR: CEO reported significant disposal of common stock and receipt of multiple time‑based RSU grants with staggered vesting.
The Form 4 documents a disposition of 93,864 common shares alongside grant of RSUs totaling 39, - see award lines (14,782; 12,500; 3,925; 8,785) that convert one-for-one to common stock and have defined vesting dates in 2026–2028. The awards are issued under the company’s 2021 Stock Incentive Plan and noted as exempt under Rule 16b-3, indicating standard insider compensation mechanics rather than a non‑routine transfer. The disclosure by the President & CEO meets Section 16 reporting requirements.
TL;DR: The package mixes immediate liquidity (share disposition) with long-term retention via RSUs and an exercisable option.
The report shows an immediate sale/transfer of 93,864 shares on 08/21/2025 while the officer retains or receives time‑vested incentives: RSUs with vesting in 2026–2028 and a fully exercisable 10,000‑share option at $63.17. This structure aligns with common executive compensation practices that balance near‑term monetization with multi‑year retention incentives. All grants are recorded as exempt under Rule 16b-3, signaling they follow typical company plan procedures.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 14,782 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 12,500 | $0.00 | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock, $.50 par value | -- | -- | -- |
Footnotes (1)
- These restricted stock units ("RSUs") convert into common stock on a one-for-one basis. These RSUs were granted under the Transcat, Inc. 2021 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vest on March 25, 2028. These RSUs were granted under the Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, 4,167 RSUs vest on March 28, 2026 and 8,333 RSUs vest March 27, 2027, subject to continued employment through each vesting date. These RSUs vest on March 27, 2027, except as otherwise provided in the award notice. These RSUs vest on March 28, 2026, except as otherwise provided in the award notice. This option is fully exercisable as of the date of this report.
